首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >Readily available fluorescein isothiocyanate-conjugated antibodies can be easily converted into targeted phototoxic agents for antibacterial antiviral and anticancer therapy.
【2h】

Readily available fluorescein isothiocyanate-conjugated antibodies can be easily converted into targeted phototoxic agents for antibacterial antiviral and anticancer therapy.

机译:现成的异硫氰酸荧光素偶联抗体可以轻松转换为靶向的光毒剂用于抗菌抗病毒和抗癌治疗。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fluorescein-labeled antibodies have little, if any, photodynamic effect because energy acquired by light absorption is rapidly dissipated in fluorescence. However, they can be easily and efficiently converted to selective photodynamic sensitizers by iodination under mild conditions. We have outlined general experimental procedures that can be used to turn a fluorescein-labeled anti-Escherichia coli antibody into a photodynamic sensitizer that selectively kills E. coli while sparing closely related Salmonella typhimurium. These results demonstrate that iodination did not destroy the specificity or activity of the antibody. This technique should be applicable to the large number of fluoresceinated antibodies that are commercially available. Thus, this strategy provides a simple way to rapidly prepare a large number of targeted phototoxic agents that can be used for the selective destruction with light of nearly any type of tissue or organism.
机译:荧光素标记的抗体几乎没有光动力效应,因为通过光吸收获得的能量会迅速消散在荧光中。然而,它们可以在温和的条件下通过碘化而容易而有效地转化为选择性光动力敏化剂。我们概述了可用于将荧光素标记的抗大肠杆菌抗体转变为光动力敏化剂的一般实验程序,该光敏剂可选择性杀死大肠杆菌,同时保留紧密相关的鼠伤寒沙门氏菌。这些结果证明碘化没有破坏抗体的特异性或活性。该技术应适用于大量可商购的荧光抗体。因此,该策略提供了一种快速制备大量目标光毒剂的简单方法,这些光毒剂可用于几乎任何类型的组织或生物体的光的选择性破坏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号